Novel Imaging Markers in SPMS

Novel Imaging Markers in SPMS
Conditions:   Secondary Progressive Multiple Sclerosis;   Multiple Sclerosis, Secondary Progressive;   Multiple Sclerosis
Interventions:   Drug: Ferumoxytol infusion;   Drug: Gadoteridol;   Diagnostic Test: MRI Brain and Cervical Spine
Sponsor:   University of Utah
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

May 4, 2022Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Comments